Oldham, R K <br/><br/>
Cancer biotherapy with interferon, interleukin-2 and tumor-derived activated cells (TDAC).  [electronic resource] 

 -  In vivo (Athens, Greece)   
 - 653-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0258-851X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cells, Cultured<br/>Clinical Trials as Topic<br/>Female<br/>Humans<br/>Interferons--therapeutic use<br/>Interleukin-2--therapeutic use<br/>Killer Cells, Lymphokine-Activated<br/>Lymphocyte Activation<br/>Lymphocyte Transfusion<br/>Lymphocytes, Tumor-Infiltrating<br/>Neoplasms--immunology<br/>Recombinant Proteins--therapeutic use<br/>Transplantation, Autologous